KeifeRx Alternatives & Competitors
12 companies similar to KeifeRx — KeifeRx is a biopharmaceutical company finding disease-modifying treatments for...
Companies similar to KeifeRx
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Oxford, United Kingdom
MethylGene
Harnessing Innovation to Develop Next-Generation Cancer Therapies
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Cambridge, United States
Track all KeifeRx competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
Atlanta, United States
BerGenBio ASA
Developing Innovative Drugs for Aggressive Diseases
Bergen, Norway
Pharvaris
Pioneering science for patient choice
Zug, Switzerland
Samsara Therapeutics
Treating Neurodegenerative Disease by Restoring Autophagy
Oxford, United Kingdom
China
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
AusperBio
Transforming Patient Lives For a Better Tomorrow
San Mateo, United States
About KeifeRx
KeifeRx, founded in 2019, is an emerging biopharmaceutical company headquartered in the United States. The company specializes in developing innovative treatments for neurodegenerative and immune diseases using novel tyrosine kinase inhibitors (TKIs). By focusing on low-dose, orally delivered solutions, KeifeRx address...
development of kinase inhibitors, clinical trials for neurodegenerative disease treatments, collaborative research for drug development
dementia patients, patients with neurodegenerative diseases, healthcare providers in neurology, clinical researchers
Biopharmaceutical, Clinical-stage, Neurodegenerative Diseases, Disease-modifying Treatments, Tyrosine Kinase Inhibitors, Low Dose Therapy, Orally Delivered Medication, Immune Diseases, Drug Discovery, Biotech Innovation, Pharmaceutical Research, Therapeutics Development, Medical Innovation, Biotech Startup
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches KeifeRx and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at KeifeRx on 11 Mar 2026. The 12 companies listed here were last checked between 19 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
